Mouse Anti-ATG4A Recombinant Antibody (CBT3279) (V2LY-0625-LY1044)

Umesh, Prerna, K., & Dubey, V. K. (2020). Virtual screening and repurposing of FDA-approved drugs from ZINC database to identify potential autophagy inhibitors exploiting autophagy related 4A cysteine peptidase as a target: potential as novel anti-cancer molecule. Journal of Biomolecular Structure and Dynamics, 1-17.

Yan, C., Zhao, J., Qin, Y., Zhao, F., Ji, L., & Zhang, J. (2020). Overexpression of ATG4a promotes autophagy and proliferation, and inhibits apoptosis in lens epithelial cells via the AMPK and Akt pathways. Molecular Medicine Reports, 22(2), 1295-1302.

Hait, A. S., Olagnier, D., Sancho-Shimizu, V., Skipper, K. A., Helleberg, M., Larsen, S. M., ... & Mogensen, T. H. (2020). Defects in LC3B2 and ATG4A underlie HSV2 meningitis and reveal a critical role for autophagy in antiviral defense in humans. Science immunology, 5(54), eabc2691.

Guo, L., Zhou, L., Gao, Q., Zhang, A., Wei, J., Hong, D., ... & Xu, G. (2017). MicroRNA-144-3p inhibits autophagy activation and enhances Bacillus Calmette-Guerin infection by targeting ATG4a in RAW264. 7 macrophage cells. PLoS One, 12(6), e0179772.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols